Report cover image

Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2019-2028

Publisher MarketLine
Published Sep 20, 2024
Length 305 Pages
SKU # MTLN19325943

Description

Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2019-2028


Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $261.5 billion in 2023. China was the fastest growing country with a CAGR of 7.2% over the 2019-23 period.
  • Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $161.0 billion in 2023. This was followed by India, Brazil and Russia with a value of $48.0, $30.7, and $21.8 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $217.4 billion in 2028, followed by India, Brazil, Russia with expected values of $56.0, $34.9 and $27.6 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to Buy
  • What was the size of the BRIC pharmaceuticals market by value in 2023?
  • What will be the size of the BRIC pharmaceuticals market in 2028?
  • What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC pharmaceuticals market?

Table of Contents

305 Pages
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 BRIC Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in India
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in Russia
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Company Profiles
11.1. BASF SE
11.2. Sinopharm Group Co Ltd
11.3. F. Hoffmann-La Roche Ltd
11.4. The Procter & Gamble Co
11.5. Shanghai Pharmaceuticals Holding Co Ltd
11.6. CSPC Pharmaceutical Group Ltd
11.7. Takeda Pharmaceutical Co Ltd
11.8. Novartis AG
11.9. GSK plc
11.10. AstraZeneca Plc
11.11. Sanofi
11.12. Roche Holding AG
11.13. Laboratoires Pierre Fabre SA
11.14. Ipsen SA
11.15. Les Laboratoires Servier SAS
11.16. Bayer AG
11.17. Boehringer Ingelheim GmbH
11.18. CSL Ltd
11.19. Astrazeneca Pty Ltd
11.20. Mayne Pharma Group Ltd
11.21. Hypera SA
11.22. Ache Laboratorios Farmaceuticos SA
11.23. EMS Sigma Pharma
11.24. Eurofarma Laboratorios SA
11.25. Johnson & Johnson
11.26. Sanofi-Aventis Canada Inc
11.27. Apotex Inc
11.28. Bausch Health Companies Inc
11.29. Jiangsu Hengrui Medicine Co Ltd
11.30. Lupin Ltd
11.31. Cipla Ltd
11.32. Dr. Reddy's Laboratories Ltd
11.33. PT Kalbe Farma Tbk
11.34. PT Kimia Farma Tbk
11.35. PT Tempo Scan Pacific Tbk
11.36. Pfizer Italia Srl
11.37. A. Menarini Industrie Farmaceutiche Riunite Srl
11.38. Chiesi Farmaceutici SpA
11.39. Recordati SpA
11.40. Daiichi Sankyo Co Ltd
11.41. Astellas Pharma Inc
11.42. Otsuka Holdings Co Ltd
11.43. Sanofi-Aventis de Mexico SA de CV
11.44. Genomma Lab Internacional SAB de CV
11.45. Bayer de Mexico SA de CV
11.46. Boehringer Ingelheim Mexico
11.47. Pfizer BV
11.48. Astellas Pharma Europe Ltd
11.49. Merck & Co Inc
11.50. AbbVie Inc
11.51. Pfizer Inc
11.52. Bristol-Myers Squibb Co
11.53. OTC Pharma International BV
11.54. Pharmstandard
11.55. Binnopharm Group
11.56. Novo Nordisk AS
11.57. H. Lundbeck AS
11.58. Pfizer Laboratories (Pty) Ltd
11.59. Aspen Pharmacare Holdings Ltd
11.60. Adcock Ingram Holdings Ltd
11.61. Chong Kun Dang Pharmaceutical Corp.
11.62. Yuhan Corp
11.63. Celltrion Inc
11.64. Hanmi Pharmaceuticals Co Ltd
11.65. Grifols SA
11.66. Almirall SA
11.67. Laboratorios Farmaceuticos Rovi SA
11.68. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
11.69. Deva Holding AS
12 Appendix
12.1. Methodology
12.2. About MarketLine
List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2019-28
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2019-23
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2023-28
Table 4: Brazil pharmaceuticals market value: $ billion, 2018-23
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2023
Table 6: Brazil pharmaceuticals market value forecast: $ billion, 2023-28
Table 7: Brazil Size of Population (million), 2019-23
Table 8: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 9: Brazil GDP (Current Prices, $ Billion), 2019-23
Table 10: Brazil Inflation, 2019-23
Table 11: Brazil Consumer Price Index (Absolute), 2019-23
Table 12: Brazil exchange rate, 2018-23
Table 13: China pharmaceuticals market value: $ billion, 2018-23
Table 14: China pharmaceuticals market geography segmentation: $ billion, 2023
Table 15: China pharmaceuticals market value forecast: $ billion, 2023-28
Table 16: China Size of Population (million), 2019-23
Table 17: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 18: China GDP (Current Prices, $ Billion), 2019-23
Table 19: China Inflation, 2019-23
Table 20: China Consumer Price Index (Absolute), 2019-23
Table 21: China exchange rate, 2018-23
Table 22: India pharmaceuticals market value: $ billion, 2018-23
Table 23: India pharmaceuticals market geography segmentation: $ billion, 2023
Table 24: India pharmaceuticals market value forecast: $ billion, 2023-28
Table 25: India Size of Population (million), 2019-23
Table 26: India real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 27: India GDP (Current Prices, $ Billion), 2019-23
Table 28: India Inflation, 2019-23
Table 29: India Consumer Price Index (Absolute), 2019-23
Table 30: India exchange rate, 2018-23
Table 31: Russia pharmaceuticals market value: $ billion, 2018-23
Table 32: Russia pharmaceuticals market geography segmentation: $ billion, 2023
Table 33: Russia pharmaceuticals market value forecast: $ billion, 2023-28
Table 34: Russia Size of Population (million), 2019-23
Table 35: Russia real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 36: Russia GDP (Current Prices, $ Billion), 2019-23
Table 37: Russia Inflation, 2019-23
Table 38: Russia Consumer Price Index (Absolute), 2019-23
Table 39: Russia exchange rate, 2018-23
Table 40: BASF SE: key facts
Table 41: BASF SE: Annual Financial Ratios
Table 42: BASF SE: Key Employees
Table 43: Sinopharm Group Co Ltd: key facts
Table 44: Sinopharm Group Co Ltd: Annual Financial Ratios
Table 45: Sinopharm Group Co Ltd: Key Employees
Table 46: F. Hoffmann-La Roche Ltd: key facts
Table 47: F. Hoffmann-La Roche Ltd: Key Employees
Table 48: The Procter & Gamble Co: key facts
Table 49: The Procter & Gamble Co: Annual Financial Ratios
Table 50: The Procter & Gamble Co: Key Employees
Table 51: The Procter & Gamble Co: Key Employees Continued
Table 52: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 53: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 54: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 55: CSPC Pharmaceutical Group Ltd: key facts
Table 56: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 57: CSPC Pharmaceutical Group Ltd: Key Employees
Table 58: Takeda Pharmaceutical Co Ltd: key facts
Table 59: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 60: Takeda Pharmaceutical Co Ltd: Key Employees
Table 61: Takeda Pharmaceutical Co Ltd: Key Employees Continued
Table 62: Novartis AG: key facts
Table 63: Novartis AG: Annual Financial Ratios
Table 64: Novartis AG: Key Employees
Table 65: GSK plc: key facts
Table 66: GSK plc: Annual Financial Ratios
Table 67: GSK plc: Key Employees
Table 68: AstraZeneca Plc: key facts
Table 69: AstraZeneca Plc: Annual Financial Ratios
Table 70: AstraZeneca Plc: Key Employees
Table 71: Sanofi: key facts
Table 72: Sanofi: Annual Financial Ratios
Table 73: Sanofi: Key Employees
Table 74: Sanofi: Key Employees Continued
Table 75: Roche Holding AG: key facts
Table 76: Roche Holding AG: Annual Financial Ratios
Table 77: Roche Holding AG: Key Employees
Table 78: Laboratoires Pierre Fabre SA: key facts
Table 79: Laboratoires Pierre Fabre SA: Key Employees
Table 80: Ipsen SA: key facts
Table 81: Ipsen SA: Annual Financial Ratios
Table 82: Ipsen SA: Key Employees
Table 83: Ipsen SA: Key Employees Continued
Table 84: Les Laboratoires Servier SAS: key facts
Table 85: Les Laboratoires Servier SAS: Key Employees
Table 86: Bayer AG: key facts
Table 87: Bayer AG: Annual Financial Ratios
Table 88: Bayer AG: Key Employees
Table 89: Bayer AG: Key Employees Continued
Table 90: Boehringer Ingelheim GmbH: key facts
Table 91: Boehringer Ingelheim GmbH: Key Employees
List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2019-28
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2019-23
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2023-28
Figure 4: Brazil pharmaceuticals market value: $ billion, 2018-23
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 6: Brazil pharmaceuticals market value forecast: $ billion, 2023-28
Figure 7: Forces driving competition in the pharmaceuticals market in Brazil, 2023
Figure 8: Drivers of buyer power in the pharmaceuticals market in Brazil, 2023
Figure 9: Drivers of supplier power in the pharmaceuticals market in Brazil, 2023
Figure 10: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2023
Figure 11: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2023
Figure 12: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2023
Figure 13: China pharmaceuticals market value: $ billion, 2018-23
Figure 14: China pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 15: China pharmaceuticals market value forecast: $ billion, 2023-28
Figure 16: Forces driving competition in the pharmaceuticals market in China, 2023
Figure 17: Drivers of buyer power in the pharmaceuticals market in China, 2023
Figure 18: Drivers of supplier power in the pharmaceuticals market in China, 2023
Figure 19: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2023
Figure 20: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2023
Figure 21: Drivers of degree of rivalry in the pharmaceuticals market in China, 2023
Figure 22: India pharmaceuticals market value: $ billion, 2018-23
Figure 23: India pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 24: India pharmaceuticals market value forecast: $ billion, 2023-28
Figure 25: Forces driving competition in the pharmaceuticals market in India, 2023
Figure 26: Drivers of buyer power in the pharmaceuticals market in India, 2023
Figure 27: Drivers of supplier power in the pharmaceuticals market in India, 2023
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2023
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2023
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in India, 2023
Figure 31: Russia pharmaceuticals market value: $ billion, 2018-23
Figure 32: Russia pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 33: Russia pharmaceuticals market value forecast: $ billion, 2023-28
Figure 34: Forces driving competition in the pharmaceuticals market in Russia, 2023
Figure 35: Drivers of buyer power in the pharmaceuticals market in Russia, 2023
Figure 36: Drivers of supplier power in the pharmaceuticals market in Russia, 2023
Figure 37: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2023
Figure 38: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2023
Figure 39: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us